Ephedrine Sulfate Injection
Product Images NDC 68083-610

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ephedrine Sulfate (NDC 68083-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ephedrine-spl-container-carton (Ephedrine Spl Container Carton)

This text is a detailed description of Ephedrine Sulfate Injection, USP product. It includes information like dosage, ingredients, storage recommendations, manufacturer details, and usage instructions. The product is in premixed formulation, should not be diluted, and is intended for intravenous use only. It is available in single-dose vials containing 10 mL each. The container closure does not contain natural rubber latex. Storage temperature is suggested between 20-25 degrees Celsius with excursions permitted. It does not contain preservatives, and any unused portion should be discarded. The manufacturer is listed as India.*

FDA Label Image

Ephedrine-spl-container-label (Ephedrine Spl Container Label)

This is a description of NDC 68083-610-01, a premixed formulation of Ephedrine Sulfate injection manufactured by Gland Pharma Limited in India. Each single-dose vial contains 50 mg/10 mL (5 mg/mL) of Ephedrine Sulfate, equivalent to 38 mg/10 mL of ephedrine base. It is for intravenous use only and should not be diluted. The product is in a 10 mL vial and has a manufacturing information code M.L.No: 103/AP/RR/97/FR.*

FDA Label Image

Ephedrine-spl-structure (Ephedrine Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.